Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

UroGen Pharma Ltd. (URGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/27/2023 4 Robinson James A. Jr. (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 20,000 options to buy @ $8.9, valued at $178k
06/09/2023 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 30,000 restricted stock units @ $0
02/28/2023 4 Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 2,211 options to buy @ $5, valued at $11.1k
02/02/2023 4 Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 5,000 restricted stock units @ $0
Exercised 13,333 restricted stock units @ $0
Granted 75,000 restricted stock units @ $0
Granted 125,000 options to buy @ $10.39, valued at $1.3M
Granted 100,000 rights @ $0
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 409 shares @ $10.12, valued at $4.1k
Sold 1,227 shares @ $10.12, valued at $12.4k
Exercised 833 restricted stock units @ $0
Exercised 2,500 restricted stock units @ $0
Granted 20,000 restricted stock units @ $0
Granted 40,000 options to buy @ $10.39, valued at $415.6k
02/02/2023 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 248 shares @ $10.12, valued at $2.5k
Sold 991 shares @ $10.12, valued at $10k
Sold 661 shares @ $10.12, valued at $6.7k
Exercised 500 restricted stock units @ $0
Exercised 2,000 restricted stock units @ $0
Exercised 1,333 restricted stock units @ $0
Granted 10,000 restricted stock units @ $0
Granted 30,000 options to buy @ $10.39, valued at $311.7k
01/23/2023 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 122,677 options to buy @ $5, valued at $613.4k
11/09/2022 4 Wildman Daniel George (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 20,000 options to buy @ $11.88, valued at $237.6k
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 160,000 options to buy @ $5, valued at $800k
09/12/2022 4 WEN LEANA (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 20,000 options to buy @ $7.73, valued at $154.6k
09/02/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 3,241 options to buy @ $5, valued at $16.2k
09/02/2022 4 Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 3,606 shares @ $7.21, valued at $26k
Exercised 8,333 restricted stock units @ $0
08/25/2022 4 Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 1,030 options to buy @ $5, valued at $5.2k
08/25/2022 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 259 shares @ $7.81, valued at $2k
Exercised 500 restricted stock units @ $0
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2022 4 Kim Dong (CFO) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 30,000 options to buy @ $8.61, valued at $258.3k
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2022 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 111 shares @ $8.09, valued at $898
Exercised 209 restricted stock units @ $0
01/07/2022 4 Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 46,968 shares @ $9.15, valued at $429.8k
Exercised 105,689 restricted stock units @ $0
12/02/2021 4 Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Sold 3,803 shares @ $12.03, valued at $45.8k
Exercised 8,333 restricted stock units @ $0
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2021 4 Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Bought 160 shares @ $13.1, valued at $2.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy